Form 4 Tracker
Werewolf Therapeutics, Inc.
HOWL

18 insider filings · Latest: Jul 6, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 21, 2026May 26 10:18 PMLuke EvninDirector
Sale
36,387$0.42$15.3K919,060(I)

View →

May 20, 2026May 20 10:08 PMLuke EvninDirector
Sale
85,895$0.43$36.9K955,447(I)

View →

May 19, 2026May 20 10:08 PMLuke EvninDirector
Sale
62,970$0.45$28.3K1,041,342(I)

View →

May 18, 2026May 20 10:08 PMLuke EvninDirector
Sale
22,184$0.50$11.1K1,104,312(I)

View →

May 18, 2026May 18 9:03 PMMPM Oncology Innovations Fund, L.P.
Proposed Sale
63,540$0.5151$32.7K

View →

May 18, 2026May 18 9:02 PMMPM BioVentures 2014, L.P.
Proposed Sale
290,419$0.5151$149.6K

View →

May 18, 2026May 18 9:02 PMMPM BioVentures 2014 (B), L.P.
Proposed Sale
19,370$0.5151$10.0K

View →

May 18, 2026May 18 9:02 PMUBS Oncology Impact Fund, L.P.
Proposed Sale
240,280$0.5151$123.8K

View →

May 18, 2026May 18 9:01 PMMPM Asset Management LLC
Proposed Sale
45,998$0.5151$23.7K

View →

May 18, 2026May 18 9:01 PMMPM Asset Management Investors BV2014 LLC
Proposed Sale
9,996$0.5151$5.1K

View →

May 13, 2026May 13 8:06 PMLuke EvninDirector
Sale
44,679$0.54$24.1K1,126,496(I)

View →

May 12, 2026May 12 11:47 PMLuke EvninDirector
Sale
67,885$0.64$43.4K1,171,175(I)

View →

May 11, 2026May 12 11:47 PMLuke EvninDirector
Sale
33,948$0.67$22.7K1,239,060(I)

View →

May 8, 2026May 12 11:47 PMLuke EvninDirector
Sale
305,741$0.70$214.0K1,273,008(I)

View →

May 12, 2026May 12 10:26 PMRA CAPITAL MANAGEMENT, L.P.10% Owner
Sale
101,151$0.64$64.7K406,282(I)

View →

May 11, 2026May 12 10:26 PMRA CAPITAL MANAGEMENT, L.P.10% Owner
Sale
87,490$0.67$58.6K413,001(I)

View →

May 8, 2026May 12 10:26 PMRA CAPITAL MANAGEMENT, L.P.10% Owner
Sale
376,526$0.71$267.3K418,813(I)

View →

May 11, 2026May 11 8:33 PMMPM Oncology Innovations Fund, L.P.
Proposed Sale
18,485$0.68$12.6K

View →

May 11, 2026May 11 8:33 PMMPM Asset Management LLC
Proposed Sale
13,382$0.68$9.1K

View →

May 11, 2026May 11 8:32 PMMPM BioVentures 2014, L.P.
Proposed Sale
84,491$0.68$57.5K

View →

Stock Options & Derivatives

No transactions found.